Background: Abnormal liver tests and metabolic dysfunction-associated steatotic liver disease (MASLD) are common, yet the central clinical task is identifying advanced fibrosis, cirrhosis, or an alternative liver disease that requires timely investigation or referral.
Methods: We conducted a narrative review of PubMed,...
Current and developing uses of AI in cholangiocarcinoma, ranging from ambiguous biliary strictures to tailored treatment options, are outlined, and progress in this field is compared with the more mature experience of radiology, pathology, and gastrointestinal endoscopy are compared.
A. Salman, A. Elewa, A. Marwan· International Journal of Hep...· 0 citations
The recognition of environmental exposure redefines metabolic dysfunction-associated steatotic liver disease as chemical environment-driven and has implications in risk assessment, treatment, and prevention.
A. Salman, A. Elewa, Ahmad Marwan et al.· World Journal of Translation...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.